Town Health International Medical Group Limited announced that Mr. Han Wenxin has been appointed as an independent non-executive Director with effect from 15 August 2022. The biographical details of Mr. Han are set out below: Mr. Han, aged 47, obtained a degree of Bachelor of Arts from the University of International Relations in July 1997 and obtained a degree of Master of Science in International Business from the University of Nottingham in December 2007. Mr. Han has been the chairman of CCD Strategy Limited since September 2019.

Mr. Han has also been the executive director of Shanghai Hehuang Medical Technology Co. Ltd. since December 2020. Mr. Han is a vice chairman of Hainan Saint Apricot Medical Development Foundation.

Mr. Han has entered into a letter of appointment with the Company as an independent non-executive Director for a term commenced on 15 August 2022 to 31 December 2024, and he will be subject to rotation and re-election at general meeting of the Company in accordance with the bye-laws of the Company. Pursuant to the letter of appointment, Mr. Han will be entitled to an emolument of HK$16,000 per month which was determined by the Board with reference to his duties and responsibilities with the Company, the Company's remuneration policy and the prevailing market conditions. Save as disclosed above, as at the date of this announcement, Mr. Han does not (i) hold any other position with the Company or other members of the Group; and (ii) hold any other major appointment and professional qualification.

As at the date of this announcement, Mr. Han (i) did not hold any directorship in the last three years in any public companies the securities of which are listed on any securities market in Hong Kong or overseas; (ii) does not have any interests in the shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong); and (iii) does not have any relationship with any Directors, senior management, substantial or controlling shareholders (having the meanings ascribed to them in the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited of the Company. Save as disclosed above, there is no further information to be disclosed pursuant to the requirements of Rules 13.51(2)(h) to (v) of the Listing Rules and there are no other matters relating to the appointment of Mr. Han as an independent non-executive Director that need to be brought to the attention of the shareholders of the Company. Following the appointment of Mr. Han, the Board has five independent non-executive Directors, representing at least one-third of the Board and the Company has complied with Rule 3.10(A) of the Listing Rules.